Skip to main content

Advertisement

Figure 3 | BMC Cancer

Figure 3

From: Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer

Figure 3

Postoperative outcomes of 175 gastric cancer patients according to nuclear factor (erythroid-2)–related factor 2 (Nrf2) expression. Kaplan Meier analysis of the postoperative outcomes of 175 gastric cancer patients according to Nrf2 expression. Survival curves were constructed for the 175 patients that were divided into Nrf2-positive and Nrf2-negative groups. The Nrf2-positive group had a significantly poorer outcome than the Nrf2-negative group (p < 0.01).

Back to article page